Amy Dow Featured in “Law360 Life Sciences Editorial Advisory Board”Law360 February 23, 2017
Amy K. Dow, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Chicago office, has been selected to serve on Law360’s Life Sciences Editorial Advisory Board. As a result, she was featured in the article, “Law360 Life Sciences Editorial Advisory Board.” (Read the full version – subscription required.)
Following is an excerpt:
Amy K. Dow is a member in Epstein Becker Green's health care and life sciences practice in the firm's Chicago office. She primarily represents pharmaceutical, medical device and biologics manufacturers in U.S. Food and Drug Administration regulatory, fraud and abuse and transactional matters. Dow also provides health regulatory due diligence services to private equity firms and other investors in life sciences sector entities.